These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7081334)

  • 1. Prenatal diagnosis of Duchenne muscular dystrophy: failure of amniotic fluid and maternal serum N tau-methylhistidine analyses to detect affected fetuses.
    Wassner SJ; Li JB; Ladda RL; Lorenz RP; Emery AE
    Am J Obstet Gynecol; 1982 May; 143(2):216-9. PubMed ID: 7081334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of amniotic fluid 3-methyl histidine to creatinine molar ratio for the diagnosis of intrauterine growth retardation.
    Miodovnik M; Lavin JP; Gimmon Z; Hill J; Fischer JE; Barden TP
    Obstet Gynecol; 1982 Sep; 60(3):288-93. PubMed ID: 7121908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
    László A; Klujber L
    Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False elevation of amniotic fluid enzymes of relevance for prenatal diagnosis: creatine kinase measurement in relation to Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(1):35-42. PubMed ID: 6728825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase in fetal plasma and amniotic fluid unsuccessful for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1984 Jun; 18(2):231-5. PubMed ID: 6465199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid analysis of 3-methylhistidine in urine, plasma, muscle and amniotic fluid with a single high-performance liquid chromatographic system but with different ion-pairing reagents.
    Hancock WS; Harding DR; Friedman Z
    J Chromatogr; 1982 Mar; 228():273-8. PubMed ID: 7076749
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential of radioimmunoassay of myoglobin in amniotic fluid and serum in prenatal diagnosis of Duchenne muscular dystrophy.
    Hansen KN; Lademann A; Nørgaard-Pedersen B
    Lancet; 1978 Dec; 2(8102):1250-1. PubMed ID: 82750
    [No Abstract]   [Full Text] [Related]  

  • 8. Prenatal diagnosis of Duchenne muscular dystrophy by radioimmunoassay of myoglobin in amniotic fluid.
    Török O; Norregaard-Hansen K; Szokol M; Csécsei K; Harsányi A; Papp Z
    Clin Genet; 1982 May; 21(5):354-5. PubMed ID: 7116683
    [No Abstract]   [Full Text] [Related]  

  • 9. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of MLPA in the prenatal gene diagnosis of Duchenne muscular dystrophy].
    Li Q; Li SY; Zhang HM; He WZ; Ma XY; Wang XM; Xian JJ; Sun XF; Chen DJ; Yu YH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):161-4. PubMed ID: 23849935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Content of methylhistidines in normal and pathological human skeletal muscles.
    Mussini E; Cornelio F; Dworzak F; Cotellessa L; Morandi L; Colombo L; De Ponte G; Marcucci F
    Muscle Nerve; 1983; 6(6):423-9. PubMed ID: 6621612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated second trimester amniotic fluid myoglobin from a fetus with Duchenne muscular dystrophy.
    Legge M; Potter HC
    Aust N Z J Obstet Gynaecol; 1985 May; 25(2):107-8. PubMed ID: 3863584
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of Duchenne muscular dystrophy gene products in amniotic fluid and chorionic villus sampling cells.
    Prigojin H; Brusel M; Fuchs O; Shomrat R; Legum C; Nudel U; Yaffe D
    FEBS Lett; 1993 Dec; 335(2):223-30. PubMed ID: 8253201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of fetal sex by amniotic fluid testosterone and FSH, and their potential use in detecting sex linked disorders.
    Wong PY; Doran TA; Falk M; Taylor GW; Mee AV
    Clin Biochem; 1980 Jun; 13(3):135-8. PubMed ID: 6774835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
    Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
    Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ; Tomas FM; Stern LM
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid secretor typing: validation for use in prenatal prediction of myotonic dystrophy.
    Teichler-Zallen D; Doherty RA
    Clin Genet; 1980 Oct; 18(4):257-67. PubMed ID: 6449321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-deoxycortisol in amniotic fluid: prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Schumert Z; Rosenmann A; Landau H; Rösler A
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):257-60. PubMed ID: 6966984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Errors in plasma creatine kinase estimations on fetal blood samples resulting from contamination with amniotic fluid and maternal blood: relevance for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(2):119-34. PubMed ID: 6739434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.